Two agreements with Fujifilm Europe
SIGNIFICANT NEWS
FACT

DMS has announced a double agreement with Fujifilm Europe, concerning two regions: EMEA and Australia.


ANALYSIS

With the first agreement, the Biomod 3S technology, developed by AXS Medical, will be integrated into Fujifilm’s D-EVOTM GL solution. With the second one, Fujifim Europe will market the bone densitometry solutions of DMS Imaging through a distribution agreement, under the “Visionary” brand name.
The impact is hard to measure in numbers, but we note this will bring DMS additional revenues, while this further validates the group’s technologies and strategy. As we wrote in our initiation of coverage note dated July 2016, we expect further agreements to boost the group’s activities and, in this respect, the two agreements made public are very good news.


IMPACT

We will not change our numbers on this news which, however, confirms both the group’s strategy and the significant upside we see for the share price.